BSE filing, BSE: 542801. Summary written from the filing by ALFA Finder's alert engine.
Misquita Engineering Ltd: key numbers
- Share price
- ₹66.50
- Market cap
- ₹31.18 Cr
- Revenue (annual)
- ₹18.02 Cr
- Net profit (annual)
- ₹0.23 Cr
- P/E (TTM)
- 135.8×Sector 52.0×
- Promoter holding
- 69.48%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Misquita Engineering Ltd
All →Misquita Engineering Annual General Meeting
Misquita Engineering Limited held its 28th Annual General Meeting on September 30, 2026. The meeting covered adoption of financial statements and re-appointments of directors.
Misquita Engineering Management Change
Misquita Engineering re-appointed two Executive Directors, including MD Thomas Misquita, for a further 60-month term effective 7 Sep 2026. No financial impact is disclosed.
Misquita Engineering Annual Report
Misquita Engineering filed its Annual Report for FY 2025-2026 with the AGM notice under Regulation 34(1). No new transaction or monetary event is announced in the filing.
Misquita Engineering Annual General Meeting
Misquita Engineering filed the notice for its 28th AGM on 30 September 2026. Agenda covers adopting FY26 financials, director re-appointments and appointing statutory auditors.
Misquita Engineering Other Announcement
Misquita Engineering Limited announced the book closure for its upcoming Annual General Meeting (AGM) to be held on September 30, 2026.
Misquita Engineering Board Meeting Outcome
Misquita Engineering announced the board meeting outcome, covering the approval of its 28th AGM schedule, re-appointment of key directors, and appointment of statutory auditors.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.